NEW YORK (PRWEB)
March 29, 2023
Mount Sinai Health System has been named one of “America’s Most Innovative Companies 2023” by Fortune magazine in its inaugural list. Mount Sinai was recognized in the Healthcare and Social category.
Fortune’s list of America’s Most Innovative Companies is based on a holistic view of a company’s innovative activity. The companies were identified based on product innovation, process innovation, and innovation culture. Fortune partnered with Statista, an online platform specializing in market and consumer data, to deploy online surveys. Statista evaluated the companies across the country by internally viewing the process innovation and product innovation and surveying experts in various fields. Statista also collaborated with LexisNexis PatentSight to use their platform to analyze the quantity and value of a company’s patents.
The Mount Sinai Health System continues to innovate in all facets of medicine, including research and clinical trials, medical tools and technology, patient care, and more. In the past year Mount Sinai has, among other things, assisted in the development of a groundbreaking heart disease medication known as the polypill, revealed a new immunotherapy for multiple myeloma patients, identified a new gene that drives colon cancer, and identified the role of an Alzheimer’s disease risk gene in the brain.
“We are honored to receive this recognition from Fortune,” said Kenneth L. Davis, MD, Chief Executive Officer of Mount Sinai Health System. “This acknowledges Mount Sinai as a pillar in health care innovation. We find new ways to advance medicine, pushing the boundaries of science and medicine, with the overarching goal to improve health of patients everywhere.”
The America’s Most Innovative Companies list reinforces that Mount Sinai has an outstanding innovation culture and continues to modernize medicine for the future. The list honors 300 U.S.-based companies that have proved to be at the forefront of innovation in different sectors.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties. For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
Share article on social media or email: